PSAT1 was regarded as a poor prognostic marker in non-small cell lung cancer [14], esophageal squamous cell carcinoma [15], breast cancer [16] and colorectal cancer [17] and contributes to cancer cell proliferation and metastasis. Here, PSAT1 is linked to non-small cell lung carcinoma.